China begins implementing relaxed anti-COVID-19 measures
BEIJING (AP) — China began implementing a more relaxed version of its strict “zero COVID” policy on Thursday amid steps…
BEIJING (AP) — China began implementing a more relaxed version of its strict “zero COVID” policy on Thursday amid steps to restore normal life, but also trepidation over a possible broader outbreak once controls are eased.
The country reported 21,165 new coronavirus cases on Thursday, though it was unclear whether the lower number reflected fewer infections or a reduction in testing.
The National Health Commission issued relaxed anti-pandemic regulations on Wednesday, including a loosening of lockdowns and the elimination of a requirement that a recent negative COVID-19 test be shown to enter most public places.
The commission said it was due to “positive results” in fighting the virus and because of a recognition that the current omicron variant is less dangerous than earlier versions of the virus — a fact long embraced by other countries that have reopened their societies.
The relaxation also follows street protests — the largest in decades — by people fed up with the draconian controls, which have been blamed for hobbling the economy, upending millions of lives and causing the deaths of some people refused hospital treatment because they lacked proper test results.
“This is an inevitable trend. We must let go sooner or later, and we can’t always stick to previous measures,” said Xin Guijun, a 70-year-old Beijing resident.
“However, one thing is that we are on our own to protect ourselves, and we must cultivate our own awareness of personal protection,” Xin told The Associated Press.
While the relaxation sent a wave of relief through Chinese society, much uncertainty remains and the move was not met with universal acclaim.
Dr. Anthony Fauci, the top U.S. infectious disease expert and a critic of China’s reliance on lockdowns, said China risked unleashing a new wave of virus mutations on the world if it doesn’t “mount and implement a proactive vaccination campaign.”
“Whenever you have a large wave of transmissions of a virus, you give it ample opportunity to mutate,” Fauci said Wednesday at an event organized by the Financial Times newspaper.
“And when you give a virus opportunity to mutate, that allows it to form potentially new variants. And once you get a brand-new variant, that could have an impact on the rest of the world,” Fauci said.
Fauci and other foreign health officials have urged Beijing to import Western COVID-19 vaccines based on mRNA technology, considered more effective than the inactivated vaccines developed by China. Chinese officials have so far ignored such calls.
The changes announced Wednesday include a renewed commitment to vaccinate vulnerable groups and the elderly, whose levels of immunization are far lower than the population as a whole. China has administered 3.4 billion doses to its 1.4 billion people, or about 2.4 doses per person, indicating that large numbers have not received the recommended three shots.
China’s difficulties are compounded by the fact that only a small number of people have been exposed to the virus under “zero COVID,” leaving most with no natural antibodies.
In an editorial on the Wednesday announcement, the official Xinhua News Agency said the changes were “introduced based on the latest epidemic situation and mutation of the virus to contain the epidemic in a more science-based and targeted manner.”
Xinhua emphasized the need to “rectify oversimplified or one-size-fits-all approaches and excessive policy steps, oppose and curb pointless formalities and bureaucratism.”
China has not formally abandoned “zero COVID,” which seeks to track and eliminate all infections, but its recent steps seem to indicate it is dropping it in all but name.
The ruling Communist Party credits the policy with sparing China the large numbers of cases and deaths seen in other countries.
China’s official death toll is 5,235 since the start of the pandemic, versus a U.S. count of 1.1 million.
© 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
Comments are closed.